2,653
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Role of Nasal Casts for In Vitro Evaluation of Nasal Drug Delivery and Quantitative Evaluation of Various Nasal Casts

ORCID Icon, ORCID Icon & ORCID Icon
Pages 485-495 | Received 06 May 2020, Accepted 13 Jul 2020, Published online: 30 Jul 2020

References

  • XHANCE, prescribing information . Optinose US; Yardley, PA, USA (2017).
  • Messina J , CarothersJ , ObaidiMet al. Intranasal fluticasone propionate delivered by exhalation delivery system (FLU-EDS) versus Flonase® nasal spray and Flovent® HFA: a randomized comparison of bioavailability. J. Allergy Clin. Immunol.139(Suppl. 2), AB253 (2017).
  • Obaidi M , OffmanE , MessinaJet al. Improved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder. Headache.53(8), 1323–1333 (2013).
  • Azimi M , LongestPW , HindleM. Towards clinically relevant in vitro testing of locally acting nasal spray suspension products. In: Respiratory Drug Delivery Europe 2015.DalbyRN, ByronPR, PeartJet al.et al. ( Eds). DHI Publisher, IL, USA, 121–130 (2015).
  • Baraniuk JN . Neural regulation of mucosal function. Pulm. Pharmacol. Ther.21(3), 442–448 (2008).
  • Djupesland PG , SkrettingA. Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump. J. Aerosol Med. Pulm. Drug Deliv.25(5), 280–289 (2012).
  • Cole P . Nasal respiratory function. In: The Nose.Mosby-Year Book Inc, MO, USA, 3–60 (1993).
  • Suman JD , LaubeBL , DalbyR. Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition, absorption and biologic response. J. Aerosol. Med.19(4), 510–521 (2006).
  • US Food and Drug Administration Center for Drug Evaluation and Research . Draft guidance for industry: bioavailability and bioequivalence studies for nasal aerosols and nasal sprays. www.fda.gov/downloads/Drugs/./Guidances/ucm070111.pdf
  • Xi J , YuanJE , ZhangYet al. Visualization and quantification of nasal and olfactory deposition in a sectional adult nasal airway cast. Pharm. Res.33(6), 1527–1541 (2016).
  • Koken Co., Ltd . www.kokenmpc.co.jp/english/products/life_simulation_models/medical_education/lm-005/.
  • Palmer JN , JacobsonKW , MessinaJC , Kosik-GonzalezC , DjupeslandPG , MahmoudRA. EXHANCE-12: 1-year study of the exhalation delivery system with fluticasone (EDS-FLU) in chronic rhinosinusitis. Int. Forum Allergy Rhinol.8(8), 869–876 (2018).
  • Guo Y , LaubeB , DalbyR. The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model. Pharm. Res.22(11), 1871–1878 (2005).
  • Kundoor V , DalbyRN. Assessment of nasal spray deposition pattern in a silicone human nose model using a color-based method. Pharm. Res.27(1), 30–36 (2010).
  • Kundoor V , DalbyRN. Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast. Pharm. Res.28(8), 1895–1904 (2011).
  • Pu Y , GoodeyAP , FangX , JacobK. A comparison of the deposition patterns of different nasal spray formulations using a nasal cast. Aerosol Sci. Technol.48(9), 930–938 (2014).
  • Castile J , ChengYH , SimmonsBet al. Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip. Drug Dev. Ind. Pharm.39(5), 816–824 (2013).
  • Djupesland PG , MessinaJ , MahmoudR. A critical evaluation of the validity of casts for in vitro evaluation of locally acting, nasally administered drug products. Presented at: COSM 2017, CA, USA, 26–30 April 2017.
  • Liu Y , JohnsonMR , MatidaEAet al. Creation of a standardized geometry of the human nasal cavity. J. Appl. Physiol. (1985).106(3), 784–795 (2009).
  • Djupesland PG . Nasal drug delivery devices: characteristics and performance in a clinical perspective – a review. Drug Deliv. Transl. Res.3(1), 42–62 (2013).
  • Fodil R , Brugel-RibereL , CroceCet al. Inspiratory flow in the nose: a model coupling flow and vasoerectile tissue distensibility. J. Appl. Physiol. (1985).98(1), 288–295 (2005).
  • Djupesland PG , RotnesJS. Accuracy of acoustic rhinometry. Rhinology.39(1), 23–27 (2001).
  • Hilberg O . Objective measurement of nasal airway dimensions using acoustic rhinometry: methodological and clinical aspects. Allergy.57(Suppl. 70), 5–39 (2002).
  • Guilmette RA , ChengYS , GriffithWC. Characterising the variability in adult human nasal airway dimensions. Ann. Occup. Hyg.41(Suppl. 1), 491–496 (1997).
  • Gomes Ade O , Sampaio-TeixeiraAC , TrindadeSH , TrindadeIE. Nasal cavity geometry of healthy adults assessed using acoustic rhinometry. Braz. J. Otorhinolaryngol.74(5), 746–754 (2008).
  • Zhao K , JiangJ. What is normal nasal airflow? A computational study of 22 healthy adults. Int. Forum Allergy Rhinol.4(6), 435–446 (2014).
  • Leach CL , ChandR , KuehlPJ. Human clinical nasal deposition and retention from nonaqueous and aqueous steroid inhalers. In: Respiratory Drug Delivery 2016.DalbyRN, ByronPR, PeartJet al.et al. ( Eds). Virginia Commonwealth University, Richmond, VA, pp193–202 (2016).
  • Emanuel IA , BlaissMS , MeltzerEO , EvansP , ConnorA. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients. Am. J. Rhinol. Allergy.28(2), 117–121 (2014).